# A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

> **NCT01159119** · PHASE1 · TERMINATED · sponsor: **Forest Laboratories** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Pancreatitis

## Interventions

- **DRUG:** EUR-1066-A
- **DRUG:** Zenpep
- **DRUG:** EUR-1066-B

## Key facts

- **NCT ID:** NCT01159119
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08-02
- **Primary completion:** 2011-07-01
- **Final completion:** 2011-07-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159119, "A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01159119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*